Mucopolysaccharidosis Type VI - 35 Studies Found
Recruiting |
: Naglazyme After Allo Transplant for Maroteaux-Lamy Syndrome : Maroteaux-Lamy Syndrome : 2014-06-03 : Drug: Naglazyme® 1 mg per kg of body weight administered once weekly as an intravenous infusion |
Completed |
: Study of rhASB in Patients With Mucopolysaccharidosis VI : Mucopolysaccharidosis VI : 2005-02-24 :
|
Completed |
: Study of Recombinant Human N-Acetylgalactosamine 4-Sulfatase in Patients With MPS VI : Mucopolysaccharidosis VI : 2002-11-04 : Drug: N-acetylgalactosamine 4-sulfatase |
Completed |
: Open-Label Study of Efficacy and Safety of Recombinant Human N-acetylgalactosamine 4-sulfatase in Patients With MPS VI : Mucopolysaccharidosis VI : 2002-11-06 : Drug: N-acetylgalactosamine 4-sulfatase |
Completed |
: A Phase 4 Two Dose Level Study of Naglazyme(TM) (Galsulfase) in Infants With MPS VI :
|
Recruiting |
: Biomarker for Maroteaux-Lamy Disease :
: 2011-10-24 |
Completed |
: Study of Recombinant Human N-acetylgalactosamine 4-sulfatase (rhASB) in Patients With MPS VI : Mucopolysaccharidosis VI : 2003-08-20 :
|
Recruiting |
: Mucopolysaccharidosis (MPS) VI Clinical Surveillance Program (CSP) : Mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy Syndrome) : 2005-09-13 |
Completed |
: Screening an Orthopedic Population for Mildly-affected Individuals With Morquio Syndrome A and Maroteaux-Lamy Syndrome :
|